SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418,694 | +3.7% | 3,454 | -2.0% | 0.02% | +11.1% |
| Q2 2023 | $403,798 | -76.3% | 3,526 | -71.4% | 0.02% | -78.0% |
| Q1 2023 | $1,700,822 | -16.9% | 12,340 | -21.8% | 0.08% | -17.2% |
| Q4 2022 | $2,045,809 | +14.9% | 15,788 | -2.0% | 0.10% | +7.6% |
| Q3 2022 | $1,781,000 | +533.8% | 16,113 | +330.4% | 0.09% | +557.1% |
| Q2 2022 | $281,000 | -84.6% | 3,744 | -64.9% | 0.01% | -76.7% |
| Q4 2020 | $1,819,000 | +17.7% | 10,670 | -3.1% | 0.06% | -6.2% |
| Q3 2020 | $1,546,000 | -9.4% | 11,010 | +3.5% | 0.06% | -13.5% |
| Q2 2020 | $1,706,000 | +29.6% | 10,639 | -20.9% | 0.07% | -2.6% |
| Q1 2020 | $1,316,000 | -25.0% | 13,455 | -1.1% | 0.08% | +2.7% |
| Q4 2019 | $1,755,000 | +108.4% | 13,599 | +21.7% | 0.07% | +89.7% |
| Q3 2019 | $842,000 | -45.0% | 11,173 | +10.9% | 0.04% | -36.1% |
| Q2 2019 | $1,531,000 | -76.6% | 10,073 | -81.6% | 0.06% | -77.1% |
| Q1 2019 | $6,535,000 | -21.7% | 54,826 | -28.3% | 0.27% | -35.1% |
| Q4 2018 | $8,341,000 | -76.0% | 76,433 | -64.5% | 0.41% | -67.9% |
| Q3 2018 | $34,749,000 | -12.2% | 215,148 | -28.1% | 1.28% | -14.5% |
| Q2 2018 | $39,567,000 | +32.1% | 299,344 | -25.9% | 1.49% | +24.4% |
| Q1 2018 | $29,943,000 | -39.3% | 404,148 | -54.4% | 1.20% | -36.9% |
| Q4 2017 | $49,352,000 | +21.8% | 886,979 | -0.7% | 1.90% | +15.3% |
| Q3 2017 | $40,528,000 | +37.3% | 893,484 | +2.1% | 1.65% | +33.7% |
| Q2 2017 | $29,510,000 | +21.8% | 875,407 | +6.9% | 1.23% | +23.9% |
| Q1 2017 | $24,234,000 | +61.1% | 818,705 | +49.2% | 1.00% | +55.0% |
| Q4 2016 | $15,047,000 | -1.3% | 548,571 | +120.9% | 0.64% | -5.4% |
| Q3 2016 | $15,250,000 | +239.6% | 248,327 | +5.4% | 0.68% | +214.4% |
| Q2 2016 | $4,491,000 | -61.5% | 235,506 | -35.1% | 0.22% | -64.5% |
| Q3 2015 | $11,652,000 | +9.4% | 362,891 | +3.6% | 0.61% | +19.9% |
| Q2 2015 | $10,654,000 | +26.1% | 350,127 | -12.6% | 0.51% | +1.2% |
| Q3 2014 | $8,452,000 | -22.8% | 400,585 | +9.0% | 0.50% | -18.8% |
| Q2 2014 | $10,952,000 | +65.3% | 367,628 | +33.4% | 0.62% | +66.1% |
| Q1 2014 | $6,624,000 | -27.6% | 275,639 | -38.6% | 0.37% | -24.8% |
| Q4 2013 | $9,145,000 | -49.5% | 448,937 | +17.2% | 0.50% | -51.6% |
| Q3 2013 | $18,093,000 | +12.8% | 383,073 | -9.1% | 1.02% | +4.5% |
| Q2 2013 | $16,038,000 | – | 421,621 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |